Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy.

Abstract

Diabetic cardiomyopathy is characterized by reduced cardiac contractility independent of vascular disease. A contributor to contractile dysfunction in the diabetic heart is impaired sarcoplasmic reticulum function with reduced sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a) pump activity, leading to disturbed intracellular calcium handling. It is currently unclear whether increasing SERCA2a activity in hearts with existing diabetic cardiomyopathy could still improve calcium flux and contractile performance. To test this hypothesis, we generated a cardiac-specific tetracycline-inducible double transgenic mouse, which allows for doxycycline (DOX)-based inducible SERCA2a expression in which DOX exposure turns on SERCA2a expression. Isolated cardiomyocytes and Langendorff perfused hearts from streptozotocin-induced diabetic mice were studied. Our results show that total SERCA2a protein levels were decreased in the diabetic mice by 60% compared with control. SERCA2a increased above control values in the diabetic mice after DOX. Dysfunctional contractility in the diabetic cardiomyocyte was restored to normal by induction of SERCA2a expression. Calcium transients from diabetic cardiomyocytes showed a delayed rate of diastolic calcium decay of 66%, which was reverted toward normal after SERCA2a expression induced by DOX. Global cardiac function assessed in the diabetic perfused heart showed diminished left ventricular pressure, rate of contraction, and relaxation. These parameters were returned to control values by SERCA2a expression. In conclusion, we have used mice allowing for inducible expression of SERCA2a and could demonstrate that increased expression of SERCA2a leads to improved cardiac function in mice with an already established diabetic cardiomyopathy in absence of detrimental effects.

• Authors: Jorge Suarez, Brian Scott, Wolfgang H Dillmann
• Journal: American journal of physiology. Regulatory, integrative and comparative physiology (Am J Physiol Regul Integr Comp Physiol) Vol. 295 Issue 5 Pg. R1439-45 (Nov 2008) ISSN: 0363-6119 [Print] United States
• PMID: 18799637 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Anti-Bacterial Agents
• Sarcoplasmic Reticulum Calcium-Transporting ATPases
• Doxycycline
• Calcium

Topics

• Animals
• Anti-Bacterial Agents (pharmacology)
• Blotting, Western
• Calcium (metabolism)
• Calcium Signaling (physiology)
• Diabetes Mellitus, Experimental (metabolism, physiopathology)
• Diabetic Angiopathies (genetics, metabolism, physiopathology)
• Doxycycline (pharmacology)
• Echocardiography
• Heart Ventricles
• In Vitro Techniques
• Mice
• Mice, Transgenic
• Myocardial Contraction (genetics, physiology)
• Myocytes, Cardiac (physiology)
• Sarcoplasmic Reticulum Calcium-Transporting ATPases (biosynthesis, genetics)